ebomi
Colour theme
Sign in
Insider · CIK 0001632384

Galante Joseph C

CIK 0001632384 Name as filed on the most recent filing

Filed as Galante Joseph C (30)

465 transaction lines · from 30 filings · filed 2015-02-11 to 2023-01-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

465 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-07-14 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 473, acquired Open Form 4 filing 0001209191-21-051441
2021-07-13 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 494, acquired Open Form 4 filing 0001209191-21-051441
2021-07-12 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 473, acquired Open Form 4 filing 0001209191-21-051441
2021-07-09 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 444, acquired Open Form 4 filing 0001209191-21-051441
2021-07-08 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 452, acquired Open Form 4 filing 0001209191-21-051441
2021-02-09 S, Open-market sale Pinnacle Financial Partners IncPNFP 296,120, disposed Open Form 4 filing 0001567619-21-002755
2020-12-30 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 231, acquired Open Form 4 filing 0001209191-21-008244
2020-12-29 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 229, acquired Open Form 4 filing 0001209191-21-008244
2020-12-28 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 233, acquired Open Form 4 filing 0001209191-21-008244
2020-12-24 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 233, acquired Open Form 4 filing 0001209191-21-008244
2020-12-23 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 235, acquired Open Form 4 filing 0001209191-21-008244
2020-12-22 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 235, acquired Open Form 4 filing 0001209191-21-008244
2020-12-21 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 236, acquired Open Form 4 filing 0001209191-21-008244
2020-12-18 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 238, acquired Open Form 4 filing 0001209191-21-008244
2020-12-17 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 235, acquired Open Form 4 filing 0001209191-21-008244
2020-12-16 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-12-15 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-12-14 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 228, acquired Open Form 4 filing 0001209191-21-008244
2020-12-11 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 228, acquired Open Form 4 filing 0001209191-21-008244
2020-12-10 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 229, acquired Open Form 4 filing 0001209191-21-008244
2020-12-09 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-12-08 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 229, acquired Open Form 4 filing 0001209191-21-008244
2020-12-07 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 226, acquired Open Form 4 filing 0001209191-21-008244
2020-12-04 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-12-03 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-12-02 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-12-01 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 226, acquired Open Form 4 filing 0001209191-21-008244
2020-11-30 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 229, acquired Open Form 4 filing 0001209191-21-008244
2020-11-27 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 226, acquired Open Form 4 filing 0001209191-21-008244
2020-11-25 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 226, acquired Open Form 4 filing 0001209191-21-008244
2020-11-24 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-11-23 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008244
2020-11-19 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 224, acquired Open Form 4 filing 0001209191-21-008231
2020-11-18 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 226, acquired Open Form 4 filing 0001209191-21-008231
2020-11-17 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 222, acquired Open Form 4 filing 0001209191-21-008231
2020-11-16 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 229, acquired Open Form 4 filing 0001209191-21-008231
2020-11-13 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 228, acquired Open Form 4 filing 0001209191-21-008231
2020-11-12 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008231
2020-11-11 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 234, acquired Open Form 4 filing 0001209191-21-008231
2020-11-10 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 232, acquired Open Form 4 filing 0001209191-21-008231
2020-11-09 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 230, acquired Open Form 4 filing 0001209191-21-008231
2020-11-06 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 224, acquired Open Form 4 filing 0001209191-21-008231
2020-11-05 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 224, acquired Open Form 4 filing 0001209191-21-008231
2020-11-04 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 226, acquired Open Form 4 filing 0001209191-21-008231
2020-11-03 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 224, acquired Open Form 4 filing 0001209191-21-008231
2020-11-02 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 223, acquired Open Form 4 filing 0001209191-21-008231
2020-10-30 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 224, acquired Open Form 4 filing 0001209191-21-008231
2020-10-29 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 227, acquired Open Form 4 filing 0001209191-21-008231
2020-10-28 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 223, acquired Open Form 4 filing 0001209191-21-008231
2020-10-27 P, Open-market purchase Cumberland Pharmaceuticals IncCPIX 230, acquired Open Form 4 filing 0001209191-21-008231

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 464
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Galante Joseph C, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001632384

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.